Notice Title

Consent to the Distribution of New Medicines

Publication Date
13 Nov 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go6513
Title
View PDF
File Type and Size
PDF (22 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:

Brenzys (Pre-filled Syringe)

Active Ingredient:

Etanercept 50mg/mL

Dosage Form:

Solution for injection

New Zealand Sponsor:

Samsung Bioepis NZ Limited

Manufacturers:

Patheon Italia S.p.A, Milan, Italy
Catalent Belgium SA, Brussels, Belgium
   

Product:

Brenzys (Pre-filled Pen)

Active Ingredient:

Etanercept 50mg/mL

Dosage Form:

Solution for injection

New Zealand Sponsor:

Samsung Bioepis NZ Limited

Manufacturers:

Patheon Italia S.p.A, Milan, Italy
Catalent Belgium SA, Brussels, Belgium
   

Product:

Macrobid

Active Ingredients:

Nitrofurantoin 25mg
Nitrofurantoin monohydrate 80.7mg

Dosage Form:

Modified release capsule

New Zealand Sponsor:

Te Arai BioFarma Limited

Manufacturer:

Norwich Pharmaceuticals Inc, New York, United States of America


Dated this 11th day of November 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 1 September 2013).